FDMT 4D Molecular Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$13.67
· % 处于52周区间
· 高于低点
· 至高点
$6.9952周低点
$16.9352周高点
市值 (MRQ)
$755M
P/E (TTM)
-5.2
EPS (TTM)
$-2.63
收入 (TTM)
$92M
FDMT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$13.67
市值 (MRQ)
$755M
P/E (TTM)
-5.2
EPS (TTM)
$-2.63
收入 (TTM)
$92M
ROE (TTM)
-43.3%
负债/权益 (MRQ)
0.0
52周区间
$7–$17
FDMT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$85M2019-12-31 → 2025-12-31
EPS$-2.422021-12-31 → 2025-12-31
自由现金流$-110M2020-12-31 → 2025-12-31
净利率-194.7%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | FDMT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -5.25年均值 ≈-5.6 | ≈-5.6 | · | · | |
| P/S (TTM) | 8.25年均值 ≈1442.4 | ≈1442.4 | 677.9 | 低估 | |
| 市净率 (MRQ) | 1.95年均值 ≈1.9 | ≈1.9 | 2.8 | 低估 | |
| Price / FCF (股价/自由现金流) | -7.25年均值 ≈-6.7 | ≈-6.7 | · | · | |
| Price / Cash Flow (市现率) | -7.25年均值 ≈-7.2 | ≈-7.2 | · | · | |
| 市值/营收 (TTM) | 4.5 | · | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.65年均值 ≈1.9 | ≈1.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | FDMT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -214.2%5年均值 ≈-102464.4% | ≈-102464.4% | -1043.3% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -187.2%5年均值 ≈-102464.4% | ≈-102464.4% | -1043.3% | 弱 | |
| 净利润率 (TTM) | -194.7%5年均值 ≈-87852.0% | ≈-87852.0% | -989.0% | 弱 | |
| ROA (TTM) | -37.1%5年均值 ≈-30.3% | ≈-30.3% | -32.9% | 顶尖 | |
| ROE (TTM) | -43.3%5年均值 ≈-32.6% | ≈-32.6% | -39.4% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | FDMT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.0 | · | 0.0 | 高负债 | |
| 流动比率 (MRQ) | 8.05年均值 ≈13.9 | ≈13.9 | 11.3 | 低流动性 | |
| Quick Ratio (速动比率) | 9.25年均值 ≈13.5 | ≈13.5 | 6.6 | 持平 | |
| 长期负债/股东权益 (MRQ) | 0.0 | · | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | FDMT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 230194.6%5年均值 ≈46121.4% | ≈46121.4% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 200.9%5年均值 ≈42.9% | ≈42.9% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 44.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | FDMT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.25年均值 ≈0.1 | ≈0.1 | 0.0 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$434.7K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
19.8%
下次报告
十一月 09, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $-1.04 | $-1.04 | -0.29% |
| 2026年3月31日 | 五月 7, 2026 | $-1.01 | $-1.01 | 0.21% |
| 2025年12月31日 | $0.43 | $-0.78 | 155.3% | |
| 2025年9月30日 | $-1.01 | $-1.00 | -1.2% | |
| 2025年6月30日 | $-0.98 | $-0.89 | -9.7% | |
| 2025年3月31日 | $-0.86 | $-0.88 | 2.2% | |
| 2024年12月31日 | $-0.90 | $-0.83 | -7.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37.0K | $21M | $3M | $18M | $14M | $7M | |
| SG&A Expense | $49M | $47M | $36M | $33M | $28M | $17M | $14M | |
| Operating Expenses | $245M | $188M | $134M | $113M | $89M | $70M | $58M | |
| Operating Income | $-160M | $-188M | $-113M | $-110M | $-71M | $-57M | $-51M | |
| Interest Income | $19M | $27M | $12M | $3M | $137.0K | $152.0K | $2M | |
| Other Non-op | $-37.0K | $-77.0K | $-181.0K | $-35.0K | $-121.0K | $-181.0K | $-46.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-140M | $-161M | $-101M | $-107M | $-71M | $-57M | $-49M | |
| EPS (Basic) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 | · | · | |
| EPS (Diluted) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 | · | · | |
| Shares (Basic) | 57,930,180 | 53,943,741 | 39,130,067 | 32,351,221 | 27,730,420 | · | · | |
| Shares (Diluted) | 57,930,180 | 53,943,741 | 39,130,067 | 32,351,221 | 27,730,420 | · | · | |
| EBITDA | $-160M | $-188M | $-113M | $-110M | $-71M | $-57M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $149M | $249M | $52M | $153M | $277M | $50M | |
| Short-term Investments | $342M | $276M | $39M | $161M | $95M | $0 | · | |
| Receivables | · | · | · | $0 | $47.0K | $1M | $978.0K | |
| Prepaid Expense | $10M | $10M | $8M | $7M | $8M | $4M | $2M | |
| Current Assets | $413M | $435M | $297M | $221M | $256M | $283M | $53M | |
| PP&E (Net) | $15M | $20M | $20M | $22M | $14M | $5M | $5M | |
| PP&E (Gross) | $36M | $36M | $32M | $30M | $20M | $9M | $8M | |
| Accum. Depreciation | $21M | $17M | $12M | $8M | $5M | $4M | $3M | |
| Other Non-current Assets | $9M | $4M | $684.0K | $1M | $602.0K | $602.0K | $677.0K | |
| Total Assets | $567M | $560M | $340M | $262M | $353M | $288M | $58M | |
| Accounts Payable | $11M | $4M | $4M | $3M | $5M | $2M | $2M | |
| Accrued Liabilities | $27M | $19M | $12M | $9M | $8M | $8M | · | |
| Current Liabilities | $44M | $29M | $19M | $16M | $16M | $17M | $13M | |
| Capital Leases | $16M | $19M | $12M | $13M | $15M | $0 | · | |
| Other Non-current Liabilities | $138.0K | $193.0K | $248.0K | $21.0K | $120.0K | $2M | $2M | |
| Total Liabilities | $61M | $50M | $32M | $31M | $34M | $32M | $28M | |
| Common Stock | $6.0K | $5.0K | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-716M | $-576M | $-415M | $-314M | $-207M | $-136M | $-79M | |
| AOCI | $727.0K | $229.0K | $16.0K | $-1M | $-423.0K | $0 | · | |
| Stockholders' Equity | $506M | $511M | $308M | $231M | $319M | $256M | $-73M | |
| Liabilities + Equity | $567M | $560M | $340M | $262M | $353M | $288M | $58M | |
| Shares Outstanding | 57,607,874 | 45,793,942 | 43,075,218 | 32,626,627 | 32,224,524 | 26,681,983 | 5,178,955 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $4M | $2M | $2M | $1M | $1M | |
| Stock-based Comp | $22M | $26M | $20M | $17M | $14M | $5M | $4M | |
| Operating Cash Flow | $-109M | $-135M | $-76M | $-87M | $-69M | $-51M | $-37M | |
| CapEx | $536.0K | $4M | $3M | $12M | $9M | $1M | $3M | |
| Investing Cash Flow | $-93M | $-302M | $116M | $-17M | $-173M | $-1M | $-3M | |
| Stock Issued | · | · | · | $0 | $114M | $206M | · | |
| Net Stock Activity | · | · | · | $0 | $114M | · | · | |
| Financing Cash Flow | $113M | $337M | $157M | $3M | $118M | $279M | $-2M | |
| Net Change in Cash | $-89M | $-100M | $197M | $-101M | $-124M | $227M | $-42M | |
| Free Cash Flow | $-110M | $-138M | $-79M | $-98M | $-78M | $-52M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% | -416.3% | · | |
| Net Margin | -164.4% | -434778.4% | -486.6% | -3435.4% | -395.4% | -416.5% | · | |
| EBITDA Margin | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% | -416.3% | · | |
| ROA | -24.9% | -35.7% | -33.5% | -34.9% | -22.2% | -32.7% | · | |
| ROE | -30.2% | -30.2% | -31.6% | -44.5% | -26.3% | -75.0% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.4 | 14.9 | 15.7 | 14.0 | 15.7 | 16.9 | · | |
| Quick Ratio | 9.2 | 14.6 | 15.2 | 13.6 | 15.2 | 16.6 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | · | 133.1 | 23.5 | 11.0 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.78 | $11.15 | $7.15 | $7.09 | $9.90 | $9.61 | · | |
| Revenue / Share | $1.47 | $0.00 | $0.53 | $0.10 | · | · | · | |
| Cash Flow / Share | $-1.88 | $-2.49 | $-1.94 | $-2.68 | · | · | · | |
| Cash / Share | $1.05 | $3.26 | $5.78 | $1.60 | $4.75 | $10.37 | · | |
| EPS (TTM) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 230194.6% | -99.8% | 562.3% | -82.7% | 32.5% | · | · | |
| Revenue CAGR 3Y | 200.9% | -87.3% | 15.0% | · | · | · | · | |
| Revenue CAGR 5Y | 44.3% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37.0K | $21M | $3M | $18M | $14M | · | |
| Net Income TTM | $-140M | $-161M | $-101M | $-107M | $-71M | $-57M | · | |
| Market Cap | $432M | $255M | $873M | $725M | $707M | $1.11B | · | |
| P/E | -3.1 | -1.9 | -7.9 | -6.7 | -8.5 | · | · | |
| P/S | 5.1 | 6893.8 | 42.1 | 231.6 | 39.2 | 81.2 | · | |
| P/B | 0.9 | 0.5 | 2.8 | 3.1 | 2.2 | 4.3 | · | |
| P / Tangible Book | 0.9 | 0.5 | 2.8 | 3.1 | 2.2 | 4.3 | · | |
| P / Cash Flow | -4.0 | -1.9 | -11.5 | -8.4 | -10.2 | -21.7 | · | |
| P / FCF | -3.9 | -1.8 | -11.1 | -7.4 | -9.0 | -21.3 | · | |
| Earnings Yield | -32.3% | -53.5% | -12.7% | -14.9% | -11.7% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $85M | $90.0K | $15.0K | $14.0K | $1.0K | $3.0K | $5.0K | $28.0K | $-18.0K | $20M | $239.0K | $298.0K | $1M | $500.0K | |
| SG&A Expense | $13M | $12M | $13M | $12M | $12M | $13M | $13M | $13M | $11M | $10M | $11M | $9M | $9M | $8M | $8M | $8M | |
| Operating Expenses | $81M | $77M | $70M | $61M | $59M | $54M | $56M | $51M | $42M | $38M | $37M | $34M | $32M | $30M | $30M | $27M | |
| Operating Income | $-77M | $-74M | $15M | $-61M | $-59M | $-54M | $-56M | $-51M | $-42M | $-38M | $-37M | $-14M | $-32M | $-30M | $-29M | $-26M | |
| Interest Income | $4M | $5M | $5M | $4M | $5M | $6M | $6M | $7M | $8M | $6M | $4M | $4M | $3M | $1M | $1M | $795.0K | |
| Other Non-op | $-166.0K | $-4.0K | $-22.0K | $-21.0K | $-61.0K | $67.0K | $-21.0K | $-1.0K | $-45.0K | $-10.0K | $-12.0K | $-158.0K | $8.0K | $-19.0K | $2.0K | $9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Net Income | $-73M | $-69M | $19M | $-57M | $-55M | $-48M | $-50M | $-44M | $-35M | $-32M | $-32M | $-10M | $-30M | $-29M | $-27M | $-26M | |
| EPS (Basic) | $-1.04 | $-1.01 | $0.43 | $-1.01 | $-0.98 | $-0.86 | $-0.90 | $-0.79 | $-0.63 | $-0.66 | $-0.69 | $-0.24 | $-0.77 | $-0.88 | $-0.84 | $-0.79 | |
| EPS (Diluted) | $-1.04 | $-1.01 | $0.43 | $-1.01 | $-0.98 | $-0.86 | $-0.90 | $-0.79 | $-0.63 | $-0.66 | $-0.69 | $-0.24 | $-0.77 | $-0.88 | $-0.84 | $-0.79 | |
| Shares (Basic) | 70,272,018 | 68,064,586 | · | 56,126,330 | 55,927,091 | 55,744,047 | · | 55,554,476 | 55,282,754 | 49,271,984 | · | 42,256,629 | 38,335,219 | 32,723,530 | · | 32,385,791 | |
| Shares (Diluted) | 70,272,018 | 68,064,586 | · | 56,126,330 | 55,927,091 | 55,744,047 | · | 55,554,476 | 55,282,754 | 49,271,984 | · | 42,256,629 | 38,335,219 | 32,723,530 | · | 32,385,791 | |
| EBITDA | $-77M | $-74M | · | $-61M | $-59M | $-54M | · | $-51M | $-42M | $-38M | · | $-14M | $-32M | $-30M | · | $-26M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $72M | $60M | $49M | $77M | $134M | $149M | $188M | $189M | $276M | $249M | $276M | $236M | $79M | $52M | $108M | |
| Short-term Investments | $291M | $318M | $342M | $257M | $216M | $188M | $276M | $314M | $353M | $250M | $39M | $44M | $74M | $122M | $161M | $119M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $17M | $14M | $10M | $7M | $10M | $11M | $10M | $9M | $11M | $10M | $8M | $9M | $7M | $7M | $7M | $5M | |
| Current Assets | $383M | $405M | $413M | $312M | $303M | $333M | $435M | $511M | $553M | $536M | $297M | $328M | $318M | $207M | $221M | $232M | |
| PP&E (Net) | $12M | $14M | $15M | $16M | $18M | $19M | $20M | $20M | $19M | $19M | $20M | $21M | $21M | $22M | $22M | $22M | |
| PP&E (Gross) | $36M | $36M | $36M | $36M | $36M | $36M | $36M | $35M | $33M | $33M | $32M | $32M | $31M | $30M | $30M | $29M | |
| Accum. Depreciation | $23M | $23M | $21M | $20M | $19M | $18M | $17M | $15M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | |
| Other Non-current Assets | $11M | $10M | $9M | $9M | $9M | $7M | $4M | $3M | $2M | $771.0K | $684.0K | $682.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $493M | $513M | $567M | $424M | $474M | $516M | $560M | $604M | $620M | $630M | $340M | $362M | $353M | $244M | $262M | $280M | |
| Accounts Payable | $13M | $15M | $11M | $7M | $9M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | $2M | $3M | $1M | |
| Accrued Liabilities | $25M | $23M | $27M | $24M | $19M | $16M | $19M | $21M | $13M | $9M | $12M | $10M | $7M | $5M | $9M | $7M | |
| Current Liabilities | $48M | $43M | $44M | $37M | $35M | $27M | $29M | $29M | $19M | $16M | $19M | $18M | $14M | $11M | $16M | $14M | |
| Capital Leases | $14M | $15M | $16M | $17M | $17M | $18M | $19M | $20M | $10M | $11M | $12M | $12M | $13M | $13M | $13M | $14M | |
| Other Non-current Liabilities | $101.0K | $121.0K | $138.0K | $144.0K | $161.0K | $177.0K | $193.0K | $196.0K | $214.0K | $231.0K | $248.0K | $20.0K | $24.0K | $29.0K | $21.0K | $23.0K | |
| Total Liabilities | $85M | $61M | $61M | $55M | $53M | $46M | $50M | $51M | $32M | $29M | $32M | $32M | $27M | $25M | $31M | $29M | |
| Total Debt | $20M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $5.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-858M | $-785M | $-716M | $-736M | $-679M | $-624M | $-576M | $-527M | $-483M | $-448M | $-415M | $-383M | $-373M | $-343M | $-314M | $-287M | |
| AOCI | $-446.0K | $-180.0K | $727.0K | $671.0K | $337.0K | $332.0K | $229.0K | $1M | $-293.0K | $-109.0K | $16.0K | $534.0K | $345.0K | $-270.0K | $-1M | $-2M | |
| Stockholders' Equity | $408M | $452M | $506M | $369M | $421M | $470M | $511M | $553M | $588M | $601M | $308M | $330M | $325M | $219M | $231M | $251M | |
| Liabilities + Equity | $493M | $513M | $567M | $424M | $474M | $516M | $560M | $604M | $620M | $630M | $340M | $362M | $353M | $244M | $262M | $280M | |
| Shares Outstanding | 55,214,097 | 52,271,648 | 57,607,874 | 46,771,185 | 46,700,242 | 46,324,642 | 45,793,942 | 51,996,639 | 51,914,275 | 51,157,388 | 43,075,218 | 42,752,452 | 42,016,622 | 33,236,768 | 32,626,627 | 32,392,378 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $994.0K | $1M | $1M | $1M | $517.0K | |
| Stock-based Comp | $6M | $4M | $6M | $5M | $5M | $7M | $8M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $5M | |
| Restructuring | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-70M | $-68M | $29M | $-46M | $-43M | $-48M | $-46M | $-29M | $-30M | $-29M | $-25M | $-1M | $-22M | $-28M | $-22M | $-21M | |
| CapEx | · | · | $-70.0K | $-91.0K | $66.0K | $631.0K | $949.0K | $2M | $349.0K | $710.0K | $549.0K | $405.0K | $805.0K | $1M | $1M | $2M | |
| Investing Cash Flow | $26M | $69M | $-129M | $18M | $-14M | $32M | $7M | $27M | $-74M | $-263M | $-7M | $30M | $49M | $43M | $-36M | $15M | |
| Financing Cash Flow | $42M | $11M | $112M | $116.0K | $862.0K | $0 | $601.0K | $568.0K | $17M | $319M | $5M | $11M | $131M | $11M | $2M | $460.0K | |
| Net Change in Cash | $-2M | $12M | $12M | $-29M | $-56M | $-16M | $-38M | $-2M | $-87M | $26M | $-27M | $39M | $158M | $26M | $-56M | $-5M | |
| Free Cash Flow | · | · | · | · | · | $-48M | · | · | · | $-30M | · | · | · | $-29M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2037.2% | -2416.2% | · | -67983.3% | -396373.3% | -383007.1% | · | -1704400.0% | -849120.0% | -136200.0% | · | -69.2% | -13446.0% | -10102.7% | · | -5299.0% | |
| Net Margin | -1929.0% | -2256.7% | · | -63195.6% | -364386.7% | -342657.1% | · | -1461433.3% | -699060.0% | -115717.9% | · | -50.8% | -12391.6% | -9624.8% | · | -5138.2% | |
| EBITDA Margin | -2037.2% | -2416.2% | · | -67983.3% | -396373.3% | -383007.1% | · | -1704400.0% | -849120.0% | -136200.0% | · | -69.2% | -13446.0% | -10102.7% | · | -5299.0% | |
| ROA | -15.1% | -13.4% | · | -11.1% | -10.0% | -8.4% | · | -9.1% | -7.2% | -7.4% | · | -3.2% | -9.0% | -10.1% | · | -9.9% | |
| ROE | -17.6% | -14.9% | · | -12.3% | -10.8% | -9.0% | · | -9.9% | -7.6% | -7.9% | · | -3.5% | -9.9% | -11.2% | · | -10.8% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.3 | · | 8.4 | 8.7 | 12.4 | · | 17.3 | 28.5 | 32.7 | · | 18.1 | 23.1 | 18.4 | · | 17.1 | |
| Quick Ratio | 7.6 | 9.0 | · | 8.2 | 8.5 | 11.9 | · | 17.0 | 27.9 | 32.1 | · | 17.6 | 22.6 | 17.8 | · | 16.8 | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1.3 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.38 | $8.64 | · | $7.89 | $9.01 | $10.14 | · | $10.63 | $11.33 | $11.74 | · | $7.72 | $7.74 | $6.58 | · | $7.76 | |
| Revenue / Share | $0.05 | $0.04 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.48 | $0.01 | $0.01 | · | $0.02 | |
| Cash Flow / Share | · | $-1.00 | · | · | · | $-0.86 | · | · | · | $-0.59 | · | · | · | $-0.85 | · | · | |
| Cash / Share | $1.27 | $1.39 | · | $1.04 | $1.65 | $2.88 | · | $3.61 | $3.64 | $5.39 | · | $6.45 | $5.62 | $2.36 | · | $3.34 | |
| EPS (TTM) | $-2.63 | $-2.57 | · | $-3.75 | $-3.53 | $-3.18 | · | $-2.77 | $-2.22 | $-2.36 | · | $-2.73 | $-3.28 | $-3.38 | · | $-3.33 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $92M | $88M | · | $120.0K | $33.0K | $23.0K | · | $18.0K | $20M | $20M | · | $22M | $2M | $2M | · | $2M | |
| Net Income TTM | $-179M | $-161M | · | $-209M | $-196M | $-176M | · | $-143M | $-110M | $-105M | · | $-96M | $-111M | $-110M | · | $-105M | |
| Market Cap | $734M | $487M | · | $406M | $173M | $150M | · | $562M | $1.09B | $1.63B | · | $544M | $759M | $571M | · | $260M | |
| Enterprise Value | $393M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -5.1 | -3.6 | · | -2.3 | -1.1 | -1.0 | · | -3.9 | -9.5 | -13.5 | · | -4.7 | -5.5 | -5.1 | · | -2.4 | |
| P/S | 8.0 | 5.5 | · | 3387.0 | 5250.2 | 6505.6 | · | 31226.9 | 53.9 | 79.7 | · | 24.8 | 332.3 | 258.8 | · | 132.0 | |
| P/B | 1.8 | 1.1 | · | 1.1 | 0.4 | 0.3 | · | 1.0 | 1.9 | 2.7 | · | 1.6 | 2.3 | 2.6 | · | 1.0 | |
| P / Tangible Book | 1.8 | 1.1 | · | 1.1 | 0.4 | 0.3 | · | 1.0 | 1.9 | 2.7 | · | 1.6 | 2.3 | 2.6 | · | 1.0 | |
| P / Cash Flow | · | -7.1 | · | · | · | -3.1 | · | · | · | -56.0 | · | · | · | -20.5 | · | · | |
| EV / Revenue | 4.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19.8% | -27.6% | · | -43.1% | -95.2% | -98.5% | · | -25.6% | -10.6% | -7.4% | · | -21.4% | -18.1% | -19.7% | · | -41.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $85M | $37.0K | $21M | $3M | $18M |
| 营业利润率 % | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% |
| 净收入 | $-140M | $-161M | $-101M | $-107M | $-71M |
| 稀释后每股收益 (EPS) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 9.4 | 14.9 | 15.7 | 14.0 | 15.7 |
| 速动比率 | 9.2 | 14.6 | 15.2 | 13.6 | 15.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-110M | $-138M | $-79M | $-98M | $-78M |
机构持有人 (13F) 166 家申报者 · $738.3M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
166
持有价值
$738.3M
新仓位
30
已退出持仓
23
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 30 (-3 与上一季度对比) | 23 (-1 与上一季度对比) | 64 (+23 与上一季度对比) | 37 (-12 与上一季度对比) | +2.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $67162061 | 5049779 | 9.10% | 股份 |
| BlackRock, Inc. | $60462583 | 4546059 | 8.19% | 股份 |
| GOLDMAN SACHS GROUP INC | $56640284 | 4258668 | 7.67% | 股份 |
| JANUS HENDERSON GROUP PLC | $48868164 | 5247151 | 6.62% | 股份 |
| NOVO HOLDINGS A/S | $43214067 | 3249178 | 5.85% | 股份 |
| STATE STREET CORP | $38717750 | 2911109 | 5.24% | 股份 |
| BVF INC/IL | $38294544 | 2879289 | 5.19% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $29914400 | 2249203 | 4.05% | 股份 |
| Trails Edge Capital Partners, LP | $29631296 | 2227917 | 4.01% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $27917432 | 2099055 | 3.78% | 股份 |
| ARMISTICE CAPITAL, LLC | $26600000 | 2000000 | 3.60% | 股份 |
| VANGUARD GROUP INC | $23201453 | 3093527 | 3.14% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $15012796 | 1128466 | 2.03% | 股份 |
| BANK OF AMERICA CORP /DE/ | $14904964 | 1120674 | 2.02% | 股份 |
| Evergreen Quality Fund GP, Ltd. | $12654604 | 951474 | 1.71% | 股份 |
| Parkman Healthcare Partners LLC | $12610847 | 948184 | 1.71% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $9717799 | 730857 | 1.32% | 股份 |
| DEUTSCHE BANK AG\ | $9455529 | 710942 | 1.28% | 股份 |
| CITADEL ADVISORS LLC | $9145040 | 687597 | 1.24% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $8173821 | 614573 | 1.11% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7712710 | 579903 | 1.04% | 股份 |
| DIADEMA PARTNERS LP | $7595723 | 571107 | 1.03% | 股份 |
| NORTHERN TRUST CORP | $7486956 | 562929 | 1.01% | 股份 |
| ACUTA CAPITAL PARTNERS, LLC | $6753753 | 507801 | 0.91% | 股份 |
| Nuveen, LLC | $6690844 | 503071 | 0.91% | 股份 |
| MORGAN STANLEY | $6690165 | 503020 | 0.91% | 股份 |
| RTW INVESTMENTS, LP | $6327302 | 475737 | 0.86% | 股份 |
| Catalio Capital Management, LP | $6267678 | 471254 | 0.85% | 股份 |
| Schonfeld Strategic Advisors LLC | $5419350 | 407470 | 0.73% | 股份 |
| JPMORGAN CHASE & CO | $5179524 | 402137 | 0.70% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4512358 | 339275 | 0.61% | 股份 |
| Opaleye Management Inc. | $4448012 | 334437 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $3673965 | 276238 | 0.50% | 股份 |
| Burkehill Global Management, LP | $3657500 | 275000 | 0.50% | 股份 |
| UBS Group AG | $3413751 | 256673 | 0.46% | 股份 |
| Propel Bio Management, LLC | $3360298 | 252654 | 0.46% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $3223242 | 242349 | 0.44% | 股份 |
| FEDERATED HERMES, INC. | $2958132 | 222416 | 0.40% | 股份 |
| ArrowMark Colorado Holdings LLC | $2698091 | 202864 | 0.37% | 股份 |
| CITADEL ADVISORS LLC | $2679950 | 201500 | 0.36% | 买入期权 |
| Woodline Partners LP | $2660013 | 200001 | 0.36% | 股份 |
| Brevan Howard Capital Management LP | $2352105 | 176850 | 0.32% | 股份 |
| TWO SIGMA ADVISERS, LP | $2064750 | 275300 | 0.28% | 股份 |
| Bank of New York Mellon Corp | $2026079 | 152337 | 0.27% | 股份 |
| Invesco Ltd. | $2000081 | 150382 | 0.27% | 股份 |
| Perigon Wealth Management, LLC | $1944261 | 146185 | 0.26% | 股份 |
| Persistent Asset Partners Ltd | $1936281 | 145585 | 0.26% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $1864660 | 140200 | 0.25% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $1708571 | 128464 | 0.23% | 股份 |
| FMR LLC | $1706596 | 128316 | 0.23% | 股份 |
公司内部人士 21 位内幕人士 · 11 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David Kirn | President and Chief Executive Officer | 2026年9月14日 S | 767486 | 0 | 10 | $-4256922 |
| Kristian Humer | Chief Financial Officer | 2025年12月9日 A | · | 0 | 0 | $0 |
| August J Moretti | Chief Financial Officer | 2023年5月15日 M | 11045 | 0 | 0 | $0 |
| Fariborz Kamal | President & COO | 2025年3月6日 A | 4347 | 0 | 0 | $0 |
| Scott Bizily | Chief Legal Officer | 2026年9月16日 M | 8617 | 0 | 11 | $-387686 |
| Christopher Paul Simms | Chief Commercial and Business Officer | 2026年3月25日 A | · | 0 | 0 | $0 |
| Ashoo Gupta | VP, Finance and Controller | 2026年3月20日 M | 47055 | 0 | 4 | $-6735 |
| Robert Young Kim | Chief Medical Officer | 2025年3月6日 A | 1043 | 0 | 0 | $0 |
| Uneek Mehra | Chief Financial & Business Officer | 2025年3月6日 A | · | 0 | 0 | $0 |
| Robert S Fishman | Chief Medical Officer | 2022年9月1日 A | · | 0 | 0 | $0 |
| Carolyne Zimmermann | Chief Business Officer | 2022年2月1日 A | · | 0 | 0 | $0 |
| Susannah Gray | 董事 | 2026年6月17日 A | · | 0 | 0 | $0 |
| Nancy Miller-Rich | 董事 | 2026年6月17日 A | · | 0 | 0 | $0 |
| Charles Theuer | 董事 | 2026年6月17日 A | 41684 | 0 | 0 | $0 |
| Shawn Tomasello | 董事 | 2026年6月17日 A | · | 0 | 0 | $0 |
| Jacob Chacko | 董事 | 2026年6月17日 A | 0 | 0 | 0 | $0 |
| Glenn Sblendorio | 董事 | 2026年6月17日 A | · | 0 | 0 | $0 |
| John F Milligan | 董事 | 2026年6月17日 A | 100000 | 0 | 0 | $0 |
| Noriyuki Kasahara | 董事 | 2023年5月23日 A | · | 0 | 0 | $0 |
| David Schaffer | 董事 | 2021年10月22日 S | 901215 | 0 | 0 | $0 |
| Tony Dung Ling Yao | 董事 | 2020年12月15日 C | 1060880 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 26 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.77% | 35199 NS | 2026年7月31日 | N-PORT |
| IWC · iShares Trust | 0.15% | 155638 SH | 2026年9月11日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.11% | 54661 NS | 2026年7月31日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.07% | 110046 SH | 2026年8月19日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.05% | 3854 SH | 2026年10月1日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 95856 SH | 2026年10月1日 | 每日 |
| IBB · iShares Trust | 0.05% | 358089 SH | 2026年9月11日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.04% | 7559 SH | 2026年10月1日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 39920 SH | 2026年8月19日 | 每日 |
| PWS · Pacer Funds Trust | 0.03% | 747 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.02% | 1177203 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 263878 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.02% | 21908 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 171040 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 460313 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 107672 SH | 2026年8月19日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.00% | 1918 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 83526 SH | 2026年9月11日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.00% | 3158 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 12813 SH | 2026年9月3日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 44264 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9930 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13010 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1588533 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3503 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 424104 SH | 2026年9月11日 | 每日 |
FDMT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 18 位分析师
买入
中位数目标
$28.00
+104.8%
5 27.8%
强烈买入
10 55.6%
买入
3 16.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
11 位分析师 · 2026-10-03平均目标 $28.18 +106.2%
← 低于所有目标
当前价格 $13.67
最低$18.00
平均值$28.18
最高$37.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ACHV | · | -4.0 | · | · | · | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| FTH | · | · | · | · | · | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报